Morgan Stanley Cuts Clorox (CLX) EPS Ahead of Earnings, Reit Underweight
Tweet Send to a Friend
Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and sees earnings risk leading her to cut FY20/FY21 EPS estimates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE